These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 24293576)
41. One-year followup study on clinical findings and changes in magnetic resonance imaging-based disease activity scores in juvenile idiopathic arthritis. Hemke R; van Veenendaal M; van den Berg JM; Dolman KM; van Rossum MA; Maas M; Kuijpers TW J Rheumatol; 2014 Jan; 41(1):119-27. PubMed ID: 24293575 [TBL] [Abstract][Full Text] [Related]
42. Risk of Serious Infections Associated with Biologic Agents in Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analyses. Aeschlimann FA; Chong SL; Lyons TW; Beinvogl BC; Góez-Mogollón LM; Tan S; Laxer RM J Pediatr; 2019 Jan; 204():162-171.e3. PubMed ID: 30318371 [TBL] [Abstract][Full Text] [Related]
43. Biologics in juvenile idiopathic arthritis: a narrative review. Vanoni F; Minoia F; Malattia C Eur J Pediatr; 2017 Sep; 176(9):1147-1153. PubMed ID: 28725955 [TBL] [Abstract][Full Text] [Related]
44. Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation. Padeh S; Pinhas-Hamiel O; Zimmermann-Sloutskis D; Berkun Y J Pediatr; 2011 Nov; 159(5):832-837.e1-2. PubMed ID: 21621220 [TBL] [Abstract][Full Text] [Related]
45. Juvenile idiopathic arthritis in the new world of biologics. Ostring GT; Singh-Grewal D J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810 [TBL] [Abstract][Full Text] [Related]
46. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST). Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y; Clin Trials; 2018 Jun; 15(3):268-277. PubMed ID: 29542334 [TBL] [Abstract][Full Text] [Related]
47. Variation in Treatment of Children Hospitalized With New-Onset Systemic Juvenile Idiopathic Arthritis in the US. Peterson RG; Xiao R; James KE; Katcoff H; Fisher BT; Weiss PF Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1714-1721. PubMed ID: 33242366 [TBL] [Abstract][Full Text] [Related]
48. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Spiegel LR; Schneider R; Lang BA; Birdi N; Silverman ED; Laxer RM; Stephens D; Feldman BM Arthritis Rheum; 2000 Nov; 43(11):2402-9. PubMed ID: 11083261 [TBL] [Abstract][Full Text] [Related]
49. Improvements in growth parameters in children with juvenile idiopathic arthritis associated with the effect of methotrexate on disease activity. Chédeville G; Quartier P; Miranda M; Brauner R; Prieur AM Joint Bone Spine; 2005 Oct; 72(5):392-6. PubMed ID: 16087383 [TBL] [Abstract][Full Text] [Related]
50. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. Papadopoulou C; Kostik M; Böhm M; Nieto-Gonzalez JC; Gonzalez-Fernandez MI; Pistorio A; Martini A; Ravelli A J Pediatr; 2013 Sep; 163(3):879-84. PubMed ID: 23664559 [TBL] [Abstract][Full Text] [Related]
51. Linear growth in children suffering from juvenile idiopathic arthritis requiring steroid therapy: natural history and effects of growth hormone treatment on linear growth. Simon D; Lucidarme N; Prieur AM; Ruiz JC; Czernichow P J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1483-6. PubMed ID: 11837503 [TBL] [Abstract][Full Text] [Related]
52. Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates. Khawaja K; Al-Maini M Pediatr Rheumatol Online J; 2017 May; 15(1):41. PubMed ID: 28511684 [TBL] [Abstract][Full Text] [Related]
53. Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis. Berard RA; Laxer RM Expert Opin Biol Ther; 2013 Nov; 13(11):1623-30. PubMed ID: 24070010 [TBL] [Abstract][Full Text] [Related]
54. Juvenile idiopathic arthritis - what the clinician needs to know. Kahn PJ Bull Hosp Jt Dis (2013); 2013; 71(3):194-9. PubMed ID: 24151944 [TBL] [Abstract][Full Text] [Related]
55. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. De Benedetti F; Meazza C; Vivarelli M; Rossi F; Pistorio A; Lamb R; Lunt M; Thomson W; Ravelli A; Donn R; Martini A; Arthritis Rheum; 2003 May; 48(5):1398-407. PubMed ID: 12746913 [TBL] [Abstract][Full Text] [Related]
56. Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register. Anink J; Otten MH; Prince FH; Hoppenreijs EP; Wulffraat NM; Swart JF; ten Cate R; van Rossum MA; van den Berg JM; Dolman KM; Koopman-Keemink Y; Armbrust W; Kamphuis S; van Pelt PA; Gorter SL; van Suijlekom-Smit LW Rheumatology (Oxford); 2013 Apr; 52(4):712-7. PubMed ID: 23267169 [TBL] [Abstract][Full Text] [Related]
57. Description of active joint count trajectories in juvenile idiopathic arthritis. Berard RA; Tomlinson G; Li X; Oen K; Rosenberg AM; Feldman BM; Yeung RS; Bombardier C J Rheumatol; 2014 Dec; 41(12):2466-73. PubMed ID: 25274882 [TBL] [Abstract][Full Text] [Related]
58. Etanercept treatment for children with refractory juvenile idiopathic arthritis. Kuo HC; Yu HR; Wu CC; Chang LS; Yang KD J Microbiol Immunol Infect; 2011 Feb; 44(1):52-6. PubMed ID: 21531353 [TBL] [Abstract][Full Text] [Related]
59. Revising diagnosis of juvenile idiopathic arthritis in adults: a single-center retrospective study. Felis-Giemza A; Chmurzyńska K; Kołodziejczyk B; Gazda A Rheumatol Int; 2023 Jul; 43(7):1307-1311. PubMed ID: 36859560 [TBL] [Abstract][Full Text] [Related]
60. Growth and menarche during remission in children with juvenile idiopathic arthritis. Umławska W; Krzyzanowska M Med Wieku Rozwoj; 2009; 13(3):194-200. PubMed ID: 20081265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]